Sanofi
Clinical development pipeline, platform architecture, and registered trial tracking for Sanofi vaccine candidates.
Development Phase Distribution
Platform Technologies
Target Pathogens & Indications
Vaccine Pipeline Candidates (31)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
ACAM1000
Target: Smallpox
Platform: Biological (unspecified platform)
ALVAC(2) melanoma multi-antigen therapeutic vaccine
Target: Melanoma
Platform: Biological (unspecified platform)
C. difficile Toxoid Vaccine
Target: Clostridium Difficile Infection
Platform: Toxoid
CYD Dengue Vaccine
Target: Dengue
Platform: Biological (unspecified platform)
HSV 2 Formulation 1
Target: Genital Herpes
Platform: Biological (unspecified platform)
MVA Smallpox Vaccine
Target: HIV
Platform: Biological (unspecified platform)
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
Target: Meningococcal disease
Platform: Conjugate vaccine
Quadrivalent Influenza Vaccine (split virion, inactivated) High-Dose (QIV-HD)
Target: Influenza
Platform: Inactivated
Quadrivalent influenza vaccine, high-dose
Target: Influenza
Platform: Biological (unspecified platform)
Recombinant influenza vaccine (RIV4)
Target: Influenza
Platform: Protein / subunit
Sanofi Clostridium difficile toxoid vaccine
Target: Clostridium Difficile Infection
Platform: Biological (unspecified platform)
Sanofi SARS-CoV-2 mRNA vaccine (first-in-human formulation)
Target: COVID-19
Platform: mRNA
Trivalent inactivated influenza vaccine
Target: Influenza
Platform: Inactivated
H5 Flu IMP 2
Target: Influenza
Platform: Biological (unspecified platform)
VXB-241 240 mcg
Target: RSV
Platform: Biological (unspecified platform)
VXB-251 (RSV/hMPV/PIV3 trivalent vaccine)
Target: RSV / hMPV / PIV3
Platform: Biological (unspecified platform)
Acne mRNA vaccine
Target: Acne
Platform: mRNA
Chlamydia mRNA Vaccine
Target: Chlamydia Trachomatis Immunization
Platform: mRNA
Flu H5 egg pandemic low dose vaccine, with adjuvant
Target: Influenza
Platform: Protein / subunit
Licensed RSV Vaccine
Target: RSV
Platform: mRNA
MenACYW conjugate vaccine
Target: Meningococcal disease
Platform: Conjugate vaccine
Pandemic flu H5 HA mRNA SD2 vaccine
Target: Influenza
Platform: mRNA
RSV+HMPV vaccine
Target: RSV
Platform: Biological (unspecified platform)
Yellow fever vaccine
Target: Yellow fever
Platform: Biological (unspecified platform)
MenAC conjugate vaccine
Target: Meningococcal disease
Platform: Conjugate vaccine
MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur I
Target: Meningococcal disease
Platform: Conjugate vaccine
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine
Target: Meningococcal disease
Platform: Conjugate vaccine
Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M
Target: COVID-19
Platform: Protein / subunit
PCV21
Target: Pneumococcal disease
Platform: Conjugate vaccine
Sanofi PCV21 (21-valent pneumococcal conjugate vaccine)
Target: Pneumococcal disease
Platform: Conjugate vaccine
Yellow fever vaccine (live)
Target: Yellow fever
Platform: Biological (unspecified platform)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.